Target intelligence / Profile preview

SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2 (SPOCK2)

Target
SPOCK2
Molecular classification
Other, Extracellular matrix (ECM) protein, Proteoglycan, Matricellular protein
01

Overview

SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2, also known as SPOCK2 or Testican-2, is a member of the SPARC family of calcium-binding proteoglycans predominantly located in the extracellular matrix (ECM). This protein's structure consists of several domains, including a follistatin-like domain, a thyroglobulin type-1 domain with a characteristic CWCV motif, and an acidic C-terminal region with glycosaminoglycan-binding sites. SPOCK2 is involved in neurogenesis, ECM assembly, collagen binding, and cell-matrix adhesion; it is also linked to conditions such as cancer and bronchopulmonary dysplasia. Although structurally homologous to some signaling and adhesion molecules, SPOCK2 itself is not currently considered a classical therapeutic target, like a receptor or enzyme. No drugs or reliable biomarker roles are described for SPOCK2 to date.

Other names
Testican-2KIAA0275TICN2sparc/osteonectin, cwcv and kazal like domains proteoglycan 2SPARC/osteonectin, CWCV and Kazal-like domains proteoglycan 2Sparc/Osteonectin, Cwcv And Kazal-Like Domains Proteoglycan (Testican) 2
02

Biological functions

Extracellular matrix organizationCalcium ion bindingNeurogenesisCell-matrix interactionCell adhesionCollagen binding
03

Disease associations

CancerBronchopulmonary dysplasiaPotential role in neurodevelopmental disease

Beyond the preview

Go deeper on SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2 (SPOCK2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2 (SPOCK2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call